Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I
2022 · Molecular Therapy — Methods & Clinical Development · 6 citations
https://doi.org/10.1016/j.omtm.2022.07.015
C
Cristina Mesa-Núñez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
197
Citations
6
h-index
4
i10-index
Cristina Mesa-Núñez is an academic researcher from The San Raffaele Telethon Institute for Gene Therapy. The author has contributed to research in topics: Virus-based gene therapy research & Immunodeficiency and Autoimmune Disorders & Cell Adhesion Molecules Research. The author has an h-index of 6, co-authored 16 publications.
ORCID: 0000-0003-0581-0988Papers by this author
worksEarly bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities
2024 · Journal of Allergy and Clinical Immunology · 6 citations
https://doi.org/10.1016/j.jaci.2024.09.007
The downregulated membrane expression of CD18 in CD34+ cells defines a primitive population of human hematopoietic stem cells
2020 · Stem Cell Research & Therapy · 5 citations
https://doi.org/10.1186/s13287-020-01672-0
A Short and Efficient Transduction Protocol for Mouse Hematopoietic Stem Cells with Lentiviral Vectors
2017 · Human Gene Therapy Methods · 3 citations
https://doi.org/10.1089/hgtb.2017.100
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat